Advertisement
Australia markets close in 4 hours 43 minutes
  • ALL ORDS

    7,836.20
    -95.80 (-1.21%)
     
  • ASX 200

    7,573.90
    -90.20 (-1.18%)
     
  • AUD/USD

    0.6473
    -0.0007 (-0.10%)
     
  • OIL

    81.19
    -0.74 (-0.90%)
     
  • GOLD

    2,298.00
    -4.90 (-0.21%)
     
  • Bitcoin AUD

    93,007.19
    -6,286.07 (-6.33%)
     
  • CMC Crypto 200

    1,284.97
    -54.09 (-4.04%)
     
  • AUD/EUR

    0.6069
    +0.0003 (+0.05%)
     
  • AUD/NZD

    1.0991
    +0.0000 (+0.00%)
     
  • NZX 50

    11,867.20
    -90.30 (-0.76%)
     
  • NASDAQ

    17,440.69
    -342.02 (-1.92%)
     
  • FTSE

    8,144.13
    -2.90 (-0.04%)
     
  • Dow Jones

    37,815.92
    -570.17 (-1.49%)
     
  • DAX

    17,932.17
    -186.15 (-1.03%)
     
  • Hang Seng

    17,763.03
    +16.12 (+0.09%)
     
  • NIKKEI 225

    38,129.37
    -276.29 (-0.72%)
     

Positive Signs As Multiple Insiders Buy Microba Life Sciences Stock

It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it happened in Microba Life Sciences Limited's (ASX:MAP) case, it's fantastic news for shareholders.

Although we don't think shareholders should simply follow insider transactions, we do think it is perfectly logical to keep tabs on what insiders are doing.

View our latest analysis for Microba Life Sciences

The Last 12 Months Of Insider Transactions At Microba Life Sciences

In the last twelve months, the biggest single purchase by an insider was when Non-Executive Director Richard Bund bought AU$450k worth of shares at a price of AU$0.23 per share. That means that an insider was happy to buy shares at above the current price of AU$0.20. While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. To us, it's very important to consider the price insiders pay for shares. As a general rule, we feel more positive about a stock if insiders have bought shares at above current prices, because that suggests they viewed the stock as good value, even at a higher price.

ADVERTISEMENT

Microba Life Sciences insiders may have bought shares in the last year, but they didn't sell any. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. By clicking on the graph below, you can see the precise details of each insider transaction!

insider-trading-volume
insider-trading-volume

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of growing companies that insiders are buying.

Does Microba Life Sciences Boast High Insider Ownership?

Many investors like to check how much of a company is owned by insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Insiders own 15% of Microba Life Sciences shares, worth about AU$13m, according to our data. However, it's possible that insiders might have an indirect interest through a more complex structure. Whilst better than nothing, we're not overly impressed by these holdings.

So What Do The Microba Life Sciences Insider Transactions Indicate?

There haven't been any insider transactions in the last three months -- that doesn't mean much. But insiders have shown more of an appetite for the stock, over the last year. Overall we don't see anything to make us think Microba Life Sciences insiders are doubting the company, and they do own shares. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Microba Life Sciences. Case in point: We've spotted 4 warning signs for Microba Life Sciences you should be aware of.

Of course Microba Life Sciences may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.